Conflicts of interest: EMA survives probe, but must get better
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has managed to convince the European Parliament that it has taken the necessary steps to address the transparency and conflict of interest questions that have continued to haunt the agency over the past couple of years, thereby clearing the way for the parliament to approve its 2010 accounts.